NCT06795165View on ClinicalTrials.gov

Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 2, 2025

Primary Completion Date

April 28, 2025

Study Completion Date

June 15, 2025

Conditions
Blepharitis
Interventions
DRUG

Moxidectin 2 MG Oral Tablet

active medication

DRUG

Placebo

placebo pills

Trial Locations (1)

92663

Eye Research Foundation, Inc., Newport Beach

Sponsors
All Listed Sponsors
lead

Eye Research Foundation, Inc.

INDUSTRY